1. Dean KL. Hyperimmune eggs capture natural immune support. Altern Complemen Ther. June 2000;6(3):118-24. http://www.ah-gene.com.tw/pic/digi/71014101140_hug1.pdf. Accessed December 29, 2014.
2. Sarker SA, Casswall TH, Juneja LR, et al. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutr.
2001 Jan;32(1):19-25. [PMID: 11176319]
3. Mine Y, Kovacs-Nolan J. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: a review. J Med Food. 2002 Fall;5(3):159-69. [PMID: 12495588]
4. Xie YM, Gao S, Wang LY, et al. Therapeutic effect of probiotics and oral IgY as supplementary drugs in the treatment of pediatric rotavirus enteritis: a comparative study [in Chinese]. Zhongguo Dang Dai Er
Ke Za Zhi. 2013 Nov;15(11):1000-05. [PMID: 24229598]
5. Rahman S, Van Nguyen S, Icatlo FC Jr, et al. Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases. Hum Vaccin Immunother. 2013
May;9(5):1039-48. [PMID: 23319156]
6. Rahman S, Higo-Moriguchi K, Htun KW, et al. Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric
patients. Vaccine. 2012 Jun 29;30(31):4661-69. [PMID: 22575165]
7. Carlander D, Kollberg H, Larsson A. Retention of specific yolk IgY in the human oral cavity. BioDrugs. 2002;16(6):433-37. [PMID: 12463766]
8. Hatta H, Tsuda K, Ozeki M, et al. Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res.
1997;31(4):268-74. [PMID: 9197932]
9. Otake S, Nishihara Y, Makimura M, et al. Protection of rats against dental caries by passive immunization with hen-egg-yolk antibody (IgY). J Dent Res. 1991 Mar;70(3):162-66. [PMID: 1825668]
10. Fujibayashi T, Nakamura M, Tominaga A, et al. Effects of IgY against Candida albicans and Candida spp. Adherence and biofilm formation. Jpn J Infect Dis. 2009 Sep;62(5):337-42. [PMID: 19762981]
11. Ikemori Y, Ohta M, Umeda K, et al. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder. Vet Microbiol. 1997
Nov;58(2-4):105-11. [PMID: 9453122]
12. Jüngling A, Wiedemann V, Kühlmann R, et al. Chicken egg antibodies for prophylaxis and therapy of infectious intestinal diseases. IV. In vitro studies on protective effects against adhesion of enterotoxogenic
Escherichia coli to isolated enterocytes. Zentralbl Veterinarmed B. 1991 Jul;38(5):373-81. [PMID: 1681635]
13. Buragohain M, Dhale G, Ghalsasi G, et al. Evaluation of hyperimmune hen egg yolk derived anti-human rotavirus antibodies (anti-hrvigy) against rotavirus infection. World Journal of Vaccines. 2012;2:73-84.
http://dx.doi.org/10.4236/wjv.2012.22010. Accessed December 23, 2014.
14. Robinson RR, Feirtag J, Slavin JL. Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects. J Am Coll Nutr. 2001 Aug;20(4):279-85. [PMID: 11506055]
15. Englyst HN, Hay S, Macfarlane GT. Polysaccharide breakdown by mixed populations of human faecal bacteria. FEMS Microbiol Lett. 1987 June;45(3):163-171. doi: 10.1016/0378-1097(87)90013-9.
16. Vince AJ, McNeil NI, Wager JD, et al. The effect of lactulose, pectin, arabinogalactan, and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation
system. Br J Nutr. 1990 Jan;63(1):17-26. [PMID: 2317475]
17. Dion C, Chappuis E, Ripoll C. Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials. Nutr Metab (Lond). 2016 Apr 12;13:28. [PMID: 27073407]
18. Iyer S, Johnson WL, Nguyen L, Ross SC, Xing R, inventors; Arkion Life Sciences, LLC, assignee. Purified cytokine inhibitory factor. US patent 7,083,809 B2. Aug 1, 2006.
19. Iyer S, Nguyen TN, Wu DR, Xing R, inventors; Arkion Life Sciences, LLC, assignee. Protein isolated from egg whites and yolks of hyperimmunized animals; amino acid sequence seq id no:1 and 6;
upregulation of tumor necrosis factor and interleukins-6 and -1beta; downregulation of transforming growth factor-beta. US patent 6,420,337 B1. July 16, 2002.
20. Scheett TP, Martin T, Carr B, et al. Hyperimmune egg protein decreases submaximal heart rate and increases peak power. Poster presented at: American College of Sports Medicine Conference; May 30-June
2, 2007; New Orleans, LA. http://igyhyperimmuneegg.org/studies/Scheett_ACSM_SubmaximalHRPeakPower.pdf. Accessed January 4, 2015.
21. Scheett TP, Martin T, Carr B, et al. Increased muscular strength and enhanced muscle repair with hyperimmune egg protein supplementation. Poster presented at: National Strength and Conditioning
Association Conference; July 12-15, 2007; Atlanta, GA. http://www.igyhyperimmuneegg.org/studies/Scheett_MSCA_MuscularStrengthMuscleRepair.pdf. Accessed January 4, 2015.
22. Rivera LE, Boland CG, Scheett TP. Effect of the hyperimmune egg supplement on regulation of insulin-like growth factor 1. Paper presented at: Southeast American College of Sports Medicine Conference;
February 14-16, 2008; Birmingham, AL. http://www.seacsm.org/SEACSM_2008_program.pdf. Accessed January 2, 2015.
23. Scheett TP, Boland CG, Rivera LE, et al. Hyperimmune egg protein supplementation stimulates the GH--> IGF-1 axis. Poster presented at: National Strength and Conditioning Association Conference; July
10, 2008; Las Vegas, NV. http://www.igyhyperimmuneegg.org/studies/Scheett_Boland_Rivera_GHtoIGF-1_Axis.pdf. Accessed January 2, 2015.
24. Boland CG, Rivera LE, Scheett TP. Effect of the hyperimmune egg supplement on anabolic mediators of muscle repair. Paper presented at: Southeast American College of Sports Medicine Conference;
February 14-16, 2008; Birmingham, AL. http://www.seacsm.org/SEACSM_2008_program.pdf. Accessed January 2, 2015.
25. Kizito FB. Improvements in quality of life for HIV/AIDS patients using hyperimmune egg (Immune 26™) – The TASO Study. Paper presented at: 3rd International AIDS Society Conference on HIV Pathogenesis
and Treatment; July 24-27, 2005; Rio de Janeiro. http://www.iasociety.org/Abstracts/A2177717.aspx. Accessed December 29, 2014.
26. Karge WH, Deluca JP, Marchitelli LJ, et al. Pilot study on the effect of hyperimmune egg protein on elevated cholesterol levels and cardiovascular risk factors. J Med Food. 1999;2(2):51-63. [PMID: 19281349]
27. Greenblatt H, Adalsteinsson O, Kagen L. Administration to arthritis patients of a dietary supplement containing immune egg: an open-label pilot study. J Med Food. 1998;1(3):171-79. [on file]